A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Clinical trial NCT05899621 · RECRUITING

Trial details

NCT number: NCT05899621
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Follicular Lymphoma

Start date: 2023-06-01
Primary completion: 2025-06-30
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.